Genomatix GmbH is a computational biology company headquartered in Munich, Germany, with a seat of business in Ann Arbor, Michigan, U.S.A. Genomatix GmbH is a computational biology company headquartered in Munich, Germany, with a seat of business in Ann Arbor, Michigan, U.S.A. Genomatix was founded in 1997 by Dr. Thomas Werner as a spin-off from the Helmholtz Zentrum München (formerly 'GSF - National German Research Institute for Environment and Health'). Helmholtz Zentrum Munich is part of the Helmholtz Association of German Research Centres. Genomatix pioneered the analysis and understanding of eukaryotic gene regulation. Genomatix offers integrated solutions and databases for genome annotation and regulation analysis. Genomatix product portfolio contains solutions for: • Literature and pathway mining• Transcription factor analysis• Genome annotation integrating a wide variety of transcript sources and a special focus on regulatory regions• Analysis technology for high throughput genomic technologies (microarrays and next generation sequencing) Literature miningLitInspector is a literature search tool providing gene and signal transduction pathway mining within NCBI's PubMed database. Pathway miningGePSBiblioSphere Personalized medicine developed to a major field for Genomatix. Genomatix is involved in several projects and international conferences e.g. 5th Santorini Conference - 'Functional Genomics towards personalized health care' Since 2008 Genomatix has strongly focused on Next Generation Sequencing data analysis. Because of the large amount of data and the need for high-end computing power, Genomatix deploys its solutions as in-house installations (hardware software bundle)